Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sony Corp

Start price
Target price
Perf. (%)
€50.19
18.03.20
€90.00
04.11.21
112.71%
05.11.21

Could be worthwhile Investment >10% per year
buy
Wendy's Corp.

Start price
Target price
Perf. (%)
€6.90
18.03.20
€23.00
29.10.24
219.49%
08.12.22

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Verbund AG

Start price
Target price
Perf. (%)
€29.50
18.03.20
€45.00
08.04.20
26.31%
08.04.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Tesla Inc

Start price
Target price
Perf. (%)
€23.71
18.03.20
€20.67
22.03.20
14.82%
22.03.20

Tesla Inc

Start price
Target price
Perf. (%)
€23.71
18.03.20
€20.67
22.03.20
14.82%
22.03.20

Delta Air Lines Inc.

Start price
Target price
Perf. (%)
€27.78
18.03.20
€20.00
04.11.21
38.80%
26.05.21

buy
BlackBerry Ltd.

Start price
Target price
Perf. (%)
€2.91
17.03.20
€23.00
29.10.24
100.86%
16.09.22

buy
BlackBerry Ltd.

Start price
Target price
Perf. (%)
€2.91
17.03.20
€23.00
29.10.24
100.86%
16.09.22

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.80
17.03.20
€16.00
04.11.21
0.00%
06.01.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.80
17.03.20
€16.00
04.11.21
0.00%
06.01.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
buy
Delivery Hero SE

Start price
Target price
Perf. (%)
€57.12
17.03.20
€80.00
25.03.20
27.77%
25.03.20

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€18.36
17.03.20
€38.00
08.05.20
102.51%
08.05.20

buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.79
17.03.20
€15.00
04.11.21
200.79%
05.11.21

Could be worthwhile Investment >10% per year
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€18.58
17.03.20
-
04.11.21
373.52%
05.11.21

buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€40.55
17.03.20
€180.00
04.11.21
268.43%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
JOYY Inc. ADR

Start price
Target price
Perf. (%)
€38.95
16.03.20
€150.00
29.10.24
-13.22%
26.04.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€2.10
16.03.20
€3.00
04.11.21
418.57%
17.06.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Koninklijke Philips Electronics

Start price
Target price
Perf. (%)
€30.23
16.03.20
€40.00
04.11.21
35.28%
05.11.21

Could be worthwhile Investment >10% per year
buy
Overstock.com

Start price
Target price
Perf. (%)
€2.48
14.03.20
€75.00
04.11.21
3530.35%
05.11.21

Could be worthwhile Investment >10% per year
buy
Stratasys Inc.

Start price
Target price
Perf. (%)
€12.38
14.03.20
€17.00
04.11.21
155.74%
05.11.21

Could be worthwhile Investment >10% per year
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.65
13.03.20
€9.00
23.03.20
-10.46%
23.03.20

Could be worthwhile Investment >10% per year
buy
Oracle Corp.

Start price
Target price
Perf. (%)
€37.64
13.03.20
€50.00
18.03.20
10.53%
18.03.20

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected